1/51
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Aspirin’s Brand
Vazalore, Bayer
Diclofenac Gel’s Brand
Voltaren, Cambia, Zipsor, Zorvolex
Lidocaine Patch’s Brand
Lidoderm, Lidotral
Ibuprofen’s Brand
Motrin, Advil
Naproxen’s Brand
Naprosyn, Aleve
Indomethacin’s Brand
Indocin, Tivorbex
Meloxicam’s Brand
Mobic
Celecoxib’s Brand
Celebrex
Acetaminophen’s Brand
Tylenol
Carisoprodol’s Brand
Soma, Vanadom
Cyclobenzaprine’s
Flexeril
Methocarbamol’s Brand
Robaxin, Tanlor
Metaxalone
Skelaxin
Aspirin Therapeutic Class
Salicylate
Diclofenac Gel Therapeutic Class
NSAID
Lidocaine Path Therapeutic Class
Local Anesthetic
Ibuprofen Therapeutic Class
NSAID
Naproxen Therapeutic Class
NSAID
Indomethacin Therapeutic Class
NSAID
Meloxicam Therapeutic Class
NSAID
Celecoxib Therapeutic Class
COX-2 Inhibitor
Acetaminophen Therapeutic Class
Analgesic
Carisoprodol Therapeutic Class
Centrally Acting Skeletal Muscle Relaxant (C-IV)
Cyclobenzaprine Therapeutic Class
Centrally Acting Skeletal Muscle Muscle Relaxant
Methocarbamol Therapeutic Class
Centrally Acting Skeletal Muscle Relaxant
Metaxalone Therapeutic Class
Centrally Acting Skeletal Muscle Relaxant
Aspirin MOA
Inhibits Platelet Aggregation By Irreversibly Inhibiting COX (Preventing Production of Thromboxane A[2] Which is A Powerful Inducer of Platelet Aggregation and Vasoconstriction)
Diclofenac Gel MOA
Non-Selective COX-1 and COX-2 Inhibitor, Blocks specific enzymes that trigger pain and swelling at the application site
Lidocaine Patch MOA
Targets the peripheral nervous system and relieves pain by blocking sodium channels in nerve endings directly beneath the skin
Ibuprofen MOA
Non-Selective COX-1 and COX-2 Inhibitor, Reversibly Alters Platelet Function and Prolongs Bleeding Time
Naproxen MOA
Non-Selective COX-1 and COX-2 Inhibitor
Indomethacin MOA
Non-Selective COX-1 and COX-2 Inhibitor, Reversibly Alter Platelet Function and Prolongs Bleeding Time
Meloxicam MOA
Non-Selective COX-1 and COX-2 Inhibitor, Results In Decreased Formation of Prostaglandin Precursors, Reversibly Alters Platelet Function, and Prolongs Bleeding Time (Has Antipyretic, Analgesic, and Anti-Inflammatory Properties)
Celecoxib
Inhibits COX-2 Enzyme Isoform Which Is Thought To Be Responsible For Anti-Inflammatory Effects of NSAIDs
Acetaminophen MOA
Centrally Acting Analgesic and Antipyretic With Minimal Anti-Inflammatory Properties, Mechanism is Unknown But May Be Through Central Inhibition of Prostaglandin Synthesis
Carisoprodol MOA
Block Intraneuronal Activity in Descending Reticular Formation and Spinal Cord, Results in Muscle Relaxation
Cyclobenzaprine MOA
Relieves Skeletal Muscle Spasm of Local Origin Without Interfering With Function Function But Is Ineffective In Muscle Spasm Due To CNS Disease, Evidence Suggests That Net Effect Drug Is A Reduction In Tonic Motor Activity Influencing Both Gamma and Alpha Motor Systems
Methocarbamol MOA
Has Not Been Established In Humans, May Be Due To General CNS Depression, There Is No Direct Action On The Contractile Mechanism Of Striated Muscle, The Motor End Plate, Or The Nerve Fiber
Metaxalone MOA
Has Not Been Established In Humans, May Be Due To General CNS Depression, There Is No Direct Action On The Contractile Mechanism Of Striated Muscle, The Motor End Plate, Or The Nerve Fiber
Aspirin Adult Starting Dose
325 to 625 mg po q6h prn [max 4 g/d]
Diclofenac Gel Adult Starting Dose
50 mg po tid prn [max 200 mg/d]
Lidocaine Patch Adult Starting Dose
1 to 3 Patches (12 h on, 12 h off)
Ibuprofen Adult Starting Dose
200 to 400 mg po q4-6h prn [max1,200 mg/d OTC and 3,200 mg/d Rx]
Naproxen Adult Starting Dose
500 mg po q 12h prn [max 1,000-1,500 mg/d Rx]
Indomethacin Adult Starting Dose
50 mg po bid-tid [max 200 mg/d]
Meloxicam Adult Starting Dose
7.5 mg po daily [15 mg/d]
Celecoxib Adult Starting Dose
100 mg bid or 200 mg po daily; for migraine acute treatment 120 mg po single dose [max 400 mg/d]
Acetaminophen Adult Starting Dose
325 to 650 mg po q4-6h or 1,000 mg po q6h prn [max 3,000-3,500 mg/d]
Carisoprodol Adult Starting Dose
250 to 350 mg po tid hs [max 1,400 po mg/d]
Cyclobenzaprine Adult Starting Dose
5 mg po tid
Methocarbamol Adult Starting Dose
1,500 mg po tid-quid for 48-72 h [max 4,500 mg/d]
Metaxolone Adult Starting Dose
800 mg po tid-qid